Cbd Life Financials
| CBDL Stock | USD 0.0005 0.0001 16.67% |
Cbd |
Understanding current and past Cbd Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cbd Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Cbd Life's assets may result in an increase in income on the income statement.
Cbd Life Stock Summary
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. Cbd Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US12482V1035 |
| Business Address | 10855 N 116th |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | lbcbioscienceinc.com |
| Phone | 480 410 6780 |
| Currency | USD - US Dollar |
Cbd Life Key Financial Ratios
There are many critical financial ratios that Cbd Life's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cbd Life Sciences reports annually and quarterly.| Return On Equity | -3.89 | |||
| Return On Asset | 0.0025 | |||
| Beta | 48.75 |
Cbd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cbd Life's current stock value. Our valuation model uses many indicators to compare Cbd Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cbd Life competition to find correlations between indicators driving Cbd Life's intrinsic value. More Info.Cbd Life Sciences is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cbd Life's earnings, one of the primary drivers of an investment's value.Cbd Life Sciences Systematic Risk
Cbd Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cbd Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Cbd Life Sciences correlated with the market. If Beta is less than 0 Cbd Life generally moves in the opposite direction as compared to the market. If Cbd Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cbd Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cbd Life is generally in the same direction as the market. If Beta > 1 Cbd Life moves generally in the same direction as, but more than the movement of the benchmark.
Cbd Life November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cbd Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cbd Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cbd Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Cbd Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cbd Life's daily price indicators and compare them against related drivers.
| Downside Deviation | 20.39 | |||
| Information Ratio | 0.0548 | |||
| Maximum Drawdown | 170.83 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 25.0 |
Other Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.